Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...

A study of more than 45,000 women found that screening women according to their level of risk was as effective in detecting tumors as the one-size-fits-most screening currently recommended. By Roni ...

For stable, symptomatic patients with suspected CAD who are deemed to be at “minimal risk” using a CT-based tool, deferral of diagnostic testing is just as safe as the usual approach and is even ...

Cascade genetic risk evaluation in families with hereditary cancer can reduce the burden of disease but the rate of germline genetic testing in relatives of patients at risk is low. We identified all ...

The NCCN's new resource educates patients on genetic testing for hereditary cancer risk, focusing on breast, ovarian, pancreatic, and prostate cancers. Advances in genetic technology, spurred by the ...

Approximately 80 percent of patients who have the hepatitis C virus may have been missed through EMR-reliant risk-based testing, according to research from the CDC. The paper, published in Clinical ...

A prospective trial of gastrointestinal cancer patients showed the feasibility of preemptive genetic testing for DPYD/UGT1A1 variants associated with increased chemotherapy toxicity. Genotype-guided ...

The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised prostate cancer.